Compare Stocks: CMPS and HELP

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CMPS Compass Pathways	$14.35 +0.9%	$13.12	$4.82 ▼ $15.87	$1.99B	2.54	2.36 million shs	2.02 million shs
HELP Cybin	$12.97 +1.0%	$9.97	$3.76 ▼ $14.35	$980.69M	0.63	1.45 million shs	1.15 million shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CMPS Compass Pathways	0.00%	+8.14%	+7.98%	+18.79%	+184.16%
HELP Cybin	0.00%	+6.14%	+13.28%	+201.63%	+1,296,999,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CMPS Compass Pathways	$14.35 +0.9%	$13.12	$4.82 ▼ $15.87	$1.99B	2.54	2.36 million shs	2.02 million shs
HELP Cybin	$12.97 +1.0%	$9.97	$3.76 ▼ $14.35	$980.69M	0.63	1.45 million shs	1.15 million shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CMPS Compass Pathways	0.00%	+8.14%	+7.98%	+18.79%	+184.16%
HELP Cybin	0.00%	+6.14%	+13.28%	+201.63%	+1,296,999,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CMPS Compass Pathways	2.88	Moderate Buy	$23.36	62.77% Upside
HELP Cybin	3.00	Buy	$48.60	274.71% Upside

Current Analyst Ratings Breakdown

Latest CMPS and HELP Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/9/2026	CMPS Compass Pathways	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/20/2026	HELP Cybin	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$8.00 ➝ $62.00
8/7/2026	CMPS Compass Pathways	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$70.00 ➝ $65.00
8/6/2026	CMPS Compass Pathways	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$17.00 ➝ $18.00
8/6/2026	CMPS Compass Pathways	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$22.00 ➝ $21.00
8/6/2026	CMPS Compass Pathways	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$17.00 ➝ $22.00
8/5/2026	CMPS Compass Pathways	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
7/27/2026	CMPS Compass Pathways	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Equal Weight	$13.00
7/27/2026	CMPS Compass Pathways	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Equal Weight	$13.00
7/27/2026	HELP Cybin	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$16.00
7/17/2026	CMPS Compass Pathways	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)

(Data available from 9/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CMPS Compass Pathways	N/A	N/A	N/A	N/A	($0.55) per share	N/A
HELP Cybin	N/A	N/A	N/A	N/A	$4.49 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CMPS Compass Pathways	-$287.86M	-$4.62	N/A	N/A	N/A	N/A	-49.63%	-13.08%	11/3/2026 (Estimated)
HELP Cybin	-$148M	-$3.02	N/A	N/A	N/A	N/A	-71.78%	-64.81%	N/A

Latest CMPS and HELP Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/14/2026	Q1 2027	HELP Cybin	-$0.80	-$0.91	-$0.11	-$0.91	N/A	N/A
8/5/2026	Q2 2026	CMPS Compass Pathways	-$0.3881	-$1.88	-$1.4919	-$1.88	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CMPS Compass Pathways	N/A	N/A	N/A	N/A	N/A
HELP Cybin	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CMPS Compass Pathways	0.60	1.30	1.30
HELP Cybin	N/A	10.97	10.97

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CMPS Compass Pathways	46.19%
HELP Cybin	17.94%

Insider Ownership

Company	Insider Ownership
CMPS Compass Pathways	2.82%
HELP Cybin	15.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CMPS Compass Pathways	156	138.48 million	134.57 million	Optionable
HELP Cybin	100	75.61 million	64.27 million	N/A

CMPS and HELP Headlines

Recent News About These Companies

Insider Buying: Cybin (NASDAQ:HELP) Insider Acquires 100,000 Shares

September 12 at 6:22 AM | insidertrades.com

Eric So Purchases 100,000 Shares of Cybin (NASDAQ:HELP) Stock

September 11 at 11:07 AM | marketbeat.com

Insider Buying: Cybin (NASDAQ:HELP) Insider Purchases 100,000 Shares of Stock

September 11 at 11:07 AM | marketbeat.com

Cybin (NASDAQ:HELP) Insider Paul Glavine Acquires 100,000 Shares

September 11 at 6:37 AM | insidertrades.com

Cybin (NASDAQ:HELP) Stock Price Up 5.9% Following Insider Buying Activity

September 11 at 1:21 AM | americanbankingnews.com

Cybin (NASDAQ:HELP) Shares Down 5.5% - Here's Why

September 10 at 12:59 PM | marketbeat.com

Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York

September 10 at 7:30 AM | globenewswire.com

Cybin (NASDAQ:HELP) Insider Buys $1,178,000.00 in Stock

September 10 at 7:06 AM | marketbeat.com

Eric So Buys 100,000 Shares of Cybin (NASDAQ:HELP) Stock

September 10 at 7:06 AM | marketbeat.com

Paul Glavine Purchases 90,000 Shares of Cybin (NASDAQ:HELP) Stock

September 10 at 5:22 AM | insidertrades.com

Cybin (NASDAQ:HELP) Insider Eric So Buys 95,000 Shares

September 9, 2026 | marketbeat.com

Cybin (NASDAQ:HELP) Shares Up 5.9% After Insider Buying Activity

September 9, 2026 | marketbeat.com

Paul Glavine Buys 90,000 Shares of Cybin (NASDAQ:HELP) Stock

September 9, 2026 | marketbeat.com

Helus Pharma CEO to Spotlight Novel Mental Health Pipeline at H.C. Wainwright Conference

September 9, 2026 | tipranks.com

Helus Pharma to Participate in Fireside Chat at H.C. Wainwright Global Investment Conference

September 9, 2026 | quiverquant.comQ

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

September 9, 2026 | globenewswire.com

Helus Pharma Announces CEO Michael Halstead to Participate in Fireside Chat at Cantor Global Healthcare Conference

September 3, 2026 | quiverquant.comQ

Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York

September 3, 2026 | globenewswire.com

Pale Fire Capital SE Buys Shares of 153,505 Cybin Inc. $HELP

September 3, 2026 | marketbeat.com

Cybin (NASDAQ:HELP) Stock Price Down 4.5% - Here's What Happened

August 31, 2026 | marketbeat.com

Cybin (NASDAQ:HELP) Stock Rating Upgraded by Wall Street Zen

August 29, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CMPS and HELP Company Descriptions

Compass Pathways NASDAQ:CMPS

$14.35 +0.13 (+0.91%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$14.33 -0.02 (-0.14%)

As of 09/11/2026 07:49 PM Eastern

Compass Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to Compass Pathways plc in August 2020. Compass Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Cybin NASDAQ:HELP

$12.97 +0.13 (+1.01%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$13.02 +0.05 (+0.38%)

As of 09/11/2026 07:55 PM Eastern

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a discovery-phase phenethylamine derivative to treat neuroinflammation and psychiatric conditions. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CMPS and HELP Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CMPS and HELP Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CMPS and HELP Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CMPS and HELP Company Descriptions

Compass Pathways NASDAQ:CMPS

Cybin NASDAQ:HELP

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CMPS and HELP Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CMPS and HELP Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CMPS and HELP Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CMPS and HELP Company Descriptions

Compass Pathways NASDAQ:CMPS

Cybin NASDAQ:HELP

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools